Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171025 | 12617102 | 5 | F | 20160728 | 20160905 | 20160803 | 20160906 | EXP | DE-ROCHE-1807236 | ROCHE | 75.00 | YR | F | Y | 100.00000 | KG | 20160906 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171025 | 12617102 | 1 | PS | Rituximab | RITUXIMAB | 1 | Subcutaneous | UNKNOWN | 103705 | 1400 | MG | SOLUTION FOR INJECTION | Q3W | ||||||
| 126171025 | 12617102 | 2 | SS | Rituximab | RITUXIMAB | 1 | UNKNOWN | 103705 | |||||||||||
| 126171025 | 12617102 | 3 | SS | Rituximab | RITUXIMAB | 1 | UNKNOWN | 103705 | |||||||||||
| 126171025 | 12617102 | 4 | SS | BENDAMUSTINE | BENDAMUSTINE | 1 | Intravenous (not otherwise specified) | UNKNOWN | 0 | 180 | MG | Q3W | |||||||
| 126171025 | 12617102 | 5 | SS | BENDAMUSTINE | BENDAMUSTINE | 1 | UNKNOWN | 0 | |||||||||||
| 126171025 | 12617102 | 6 | SS | BENDAMUSTINE | BENDAMUSTINE | 1 | UNKNOWN | 0 | |||||||||||
| 126171025 | 12617102 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 126171025 | 12617102 | 8 | C | CANDESARTAN | CANDESARTAN | 1 | Oral | DOSE REDUCED | 0 | 32 | G | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126171025 | 12617102 | 1 | B-cell lymphoma |
| 126171025 | 12617102 | 2 | Diffuse large B-cell lymphoma |
| 126171025 | 12617102 | 3 | Non-Hodgkin's lymphoma |
| 126171025 | 12617102 | 4 | B-cell lymphoma |
| 126171025 | 12617102 | 5 | Diffuse large B-cell lymphoma |
| 126171025 | 12617102 | 6 | Non-Hodgkin's lymphoma |
| 126171025 | 12617102 | 7 | Lymphoma |
| 126171025 | 12617102 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126171025 | 12617102 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126171025 | 12617102 | Acute kidney injury | |
| 126171025 | 12617102 | Erythema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126171025 | 12617102 | 1 | 20160727 | 0 | ||
| 126171025 | 12617102 | 4 | 20160629 | 0 | ||
| 126171025 | 12617102 | 7 | 20160629 | 20160801 | 0 |